Zetomipzomib
Kezar Life Sciences
['lupus', 'prednisone']
#eular2023 #pos1128 promising new therapy on the block for #lupus nephritis. a single arm phase 2a study showed zetomipozomib, selective immunoproteosome-i + mmf showed about 2/3 pts met =&gt;50% reduction in upcr at wk24. no safety signal including low igg or infection 
Rheumatologist. Interested in B-cells, Lupus, Sjogren, Pre-Connective Tissue Disease, Tennis, Running & Travelling 🌏